FM
Frazier Management Portfolio holdings
AUM
$1.12M
This Quarter Return
+3.16%
1 Year Return
+150.24%
3 Year Return
+430.4%
5 Year Return
+1,926.83%
10 Year Return
–
AUM
$195M
AUM Growth
+$195M
(+4.2%)
Cap. Flow
+$12.4M
Cap. Flow
% of AUM
6.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
RXDX
Ignyta, Inc.
RXDX
|
$12.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
AnaptysBio
ANAB
$569M
| $88.3M | 45.24% | 3,688,448 | – | – |
|
2
Amicus Therapeutics
FOLD
$2.34B
| $26.2M | 13.42% | 2,600,014 | – | – |
|
3
Collegium Pharmaceutical
COLL
$1.22B
| $23.6M | 12.1% | 1,887,332 | – | – |
|
|
RXDX
4
DELISTED
Ignyta, Inc.
RXDX
| $22.5M | 11.53% | 2,173,593 +1,199,900 | +123% | +$12.4M |
|
5
Iovance Biotherapeutics
IOVA
$807M
| $15.2M | 7.8% | 2,188,331 | – | – |
|
6
Cidara Therapeutics
CDTX
$1.66B
| $9.84M | 5.04% | 1,312,258 | – | – |
|
|
SRRA
7
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $9.49M | 4.86% | 8,112,121 | – | – |
|